Accenture (ACN)
(Delayed Data from NYSE)
$355.53 USD
-5.18 (-1.44%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $355.57 +0.04 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$355.53 USD
-5.18 (-1.44%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $355.57 +0.04 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Zacks News
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Accenture (ACN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Accenture (ACN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Zacks Analyst Blog Highlights Salesforce, Accenture, Equinix and Seneca Foods
by Zacks Equity Research
Salesforce, Accenture, Equinix and Seneca Foods are included in this Analyst Blog.
Top Research Reports for Salesforce, Accenture & Equinix
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Accenture plc (ACN) and Equinix, Inc. (EQIX), as well as a micro-cap stock Seneca Foods Corporation (SENEA).
Don't Overlook Accenture (ACN) International Revenue Trends While Assessing the Stock
by Zacks Equity Research
Review Accenture's (ACN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Is It Worth Investing in Accenture (ACN) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Accenture (ACN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Accenture (ACN) Q3 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Accenture's (ACN) third-quarter fiscal 2024 earnings and revenues decline y/y.
Accenture (ACN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Accenture (ACN) give insight into how the company performed in the quarter ended May 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Accenture (ACN) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of -0.32% and 0.35%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Accenture (ACN) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Accenture's (ACN) third-quarter fiscal 2024 revenues and earnings are expected to have declined year over year.
What Analyst Projections for Key Metrics Reveal About Accenture (ACN) Q3 Earnings
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Accenture (ACN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended May 2024.
Liberty Global's (LBTYA) Acquisition to Aid Long-Term Growth
by Zacks Equity Research
Liberty Global (LBTYA) is set to acquire Formula E stakes from Warner Bros. Discovery, which is expected to aid the company's long-term prospects.
Analysts Estimate Accenture (ACN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Accenture (ACN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accenture (ACN) Announces Completion of SOKO Acquisition
by Zacks Equity Research
SOKO becomes part of Droga5 Sao Paulo, a part of Accenture (ACN) Song, bringing with it around 300 employees.
Accenture (ACN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Accenture (ACN) settling at $294.22, representing a +1.3% change from its previous close.
CyberArk (CYBR) Expands Customer Base With Coca-Cola HBC
by Zacks Equity Research
CyberArk (CYBR) expands its global footprint by adding Coca-Cola Hellenic Bottling Company to its identity security clientele.
Accenture (ACN) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the most recent trading session, Accenture (ACN) closed at $290.43, indicating a +0.7% shift from the previous trading day.
Is Accenture (ACN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Accenture (ACN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
Accenture (ACN) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Accenture (ACN) concluded the recent trading session at $281.76, signifying a -0.19% move from its prior day's close.
Do Options Traders Know Something About Accenture (ACN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Accenture (ACN) stock based on the movements in the options market lately.
Should You Invest in the iShares U.S. Industrials ETF (IYJ)?
by Zacks Equity Research
Sector ETF report for IYJ
Accenture (ACN) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the most recent trading session, Accenture (ACN) closed at $297.73, indicating a -1.08% shift from the previous trading day.
Why the Market Dipped But Accenture (ACN) Gained Today
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $307.11, marking a +1.14% move from the previous day.
Accenture (ACN) Subsidiary Completes Acquisition of Cognosante
by Zacks Equity Research
Through this acquisition, Accenture's (ACN) Accenture Federal Services is establishing a new federal health portfolio.